These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Plasma protein binding of phenytoin and warfarin in patients undergoing renal transplantation. Odar-Cederlof I Clin Pharmacokinet; 1977; 2(2):147-53. PubMed ID: 324689 [TBL] [Abstract][Full Text] [Related]
4. Intraindividual relationships between serum protein binding of drugs in normal human subjects, patients with impaired renal function, and rats. Yacobi A; Levy G J Pharm Sci; 1977 Sep; 66(9):1285-8. PubMed ID: 333094 [TBL] [Abstract][Full Text] [Related]
5. Effect of valproate on free plasma phenytoin concentrations. Tsanaclis LM; Allen J; Perucca E; Routledge PA; Richens A Br J Clin Pharmacol; 1984 Jul; 18(1):17-20. PubMed ID: 6430316 [TBL] [Abstract][Full Text] [Related]
6. Salivary phenytoin concentrations in epilepsy and in chronic renal failure. Reynolds F; Ziroyanis PN; Jones NF; Smith SE Lancet; 1976 Aug; 2(7982):384-6. PubMed ID: 73850 [TBL] [Abstract][Full Text] [Related]
7. Hemodialysis of phenytoin in a uremic patient. Adler DS; Martin E; Gambertoglio JG; Tozer TN; Spire JP Clin Pharmacol Ther; 1975 Jul; 18(1):65-9. PubMed ID: 1149364 [TBL] [Abstract][Full Text] [Related]
8. Plasma protein binding of phenytoin in 100 epileptic patients. Peterson GM; McLean S; Aldous S; Von Witt RJ; Millingen KS Br J Clin Pharmacol; 1982 Aug; 14(2):298-300. PubMed ID: 7104186 [TBL] [Abstract][Full Text] [Related]
9. Decreased plasma protein binding of phenytoin in patients on valproic acid. Dahlqvist R; Borgå O; Rane A; Walsh Z; Sjöqvist F Br J Clin Pharmacol; 1979 Dec; 8(6):547-52. PubMed ID: 391256 [TBL] [Abstract][Full Text] [Related]
10. Characterization of Free Phenytoin Concentrations in End-Stage Renal Disease Using the Winter-Tozer Equation. Soriano VV; Tesoro EP; Kane SP Ann Pharmacother; 2017 Aug; 51(8):669-674. PubMed ID: 28470115 [TBL] [Abstract][Full Text] [Related]
11. Two-fold interindividual variation in plasma protein binding of phenytoin in patients with epilepsy. Barth N; Alván G; Borgå O; Sjöqvist F Clin Pharmacokinet; 1976; 1(6):444-52. PubMed ID: 1024769 [TBL] [Abstract][Full Text] [Related]
12. Aggregation of red cells and plasma viscosity in renal patients treated by haemodialysis or kidney graft effect of proteins and ABO blood groups. Dintenfass L; Stewart JH Microvasc Res; 1974 May; 7(3):342-50. PubMed ID: 4597788 [No Abstract] [Full Text] [Related]
13. Clinical pharmacokinetics of phenytoin. Richens A Clin Pharmacokinet; 1979; 4(3):153-69. PubMed ID: 383353 [TBL] [Abstract][Full Text] [Related]
14. Morphine and phenytoin binding to plasma proteins in renal and hepatic failure. Olsen GD; Bennett WM; Porter GA Clin Pharmacol Ther; 1975 Jun; 17(6):677-84. PubMed ID: 1095281 [TBL] [Abstract][Full Text] [Related]
15. Removal of phenytoin by hemodialysis in uremic patients. Martin E; Gambertoglio JG; Adler DS; Tozer TN; Roman LA; Grausz H JAMA; 1977 Oct; 238(16):1750-3. PubMed ID: 578272 [TBL] [Abstract][Full Text] [Related]
16. Studies in man of phenytoin absorption and its implications. Gibberd FB; Webley M J Neurol Neurosurg Psychiatry; 1975 Mar; 38(3):219-24. PubMed ID: 1151402 [TBL] [Abstract][Full Text] [Related]